Scholars Central

Conference abstractPublished 23 Oct 2019

Influence of MTHFR C677T variant on high-dose methotrexate-related toxicity in tunisian acute lymphoblastic leukemia patients

Authors: Rim Frikha

Hedi Chaker University Teaching Hospital Sfax, Tunisia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: High-dose methotrexate (HD-MTX) is widely used in the acute lymphoblastic leukemia (ALL). The effect of 5, 10-methylenetetrahydrofolate reductase (MTHFR) variants; mainly the C677T on the risk of MTX-induced toxicity was largely investigated and enrolled in meta-analysis. However, the results were inconsistent. Aim: The aim of this study was to investigate the relationship between the C677T variant of the MTHFR gene, and the MTX-induced toxicity in Tunisian ALL patients. Materials & Methods: It was a retrospective study among 35 patients with ALL. Toxicity data was recorded after high-dose methotrexate (HD-MTX) course. Genotyping of MTHFR C677T was performed by polymerase chain reactionrestriction fragment length polymorphism (PCR- RFLP). Results: Patients with ALL carrying the C677T variant were at a higher risk of developing hepatotoxicity (RR=1.3 times). Conclusion: The present result highlights the impact of MTHFR C677T variant on the MTX toxicity-induced in ALL and further studies with larger numbers of participants worldwide are required before definitive conclusions.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectHaematology
  • BylineArticles whose byline prints “Rim Frikha”